Camille Sebaaly
2023
In 2023, Camille Sebaaly earned a total compensation of $695K as Chief Financial Officer at Sunshine Biopharma, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $380,000 |
|---|---|
| Salary | $315,000 |
| Total | $695,000 |
Sebaaly received $380K in bonus, accounting for 55% of the total pay in 2023.
Sebaaly also received $315K in salary.
Rankings
In 2023, Camille Sebaaly's compensation ranked 1,629th out of 2,983 executives tracked by ExecPay. In other words, Sebaaly earned more than 45.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,629 out of 2,983 | 45th |
Division Manufacturing | 950 out of 1,637 | 42nd |
Major group Chemicals And Allied Products | 608 out of 906 | 33rd |
Industry group Drugs | 592 out of 869 | 32nd |
Industry Pharmaceutical Preparations | 421 out of 627 | 33rd |
Source: SEC filing on October 17, 2024.
Sebaaly's colleagues
We found two more compensation records of executives who worked with Camille Sebaaly at Sunshine Biopharma in 2023.